183 related articles for article (PubMed ID: 32738272)
1. Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
Chaudhary S; Dam V; Ganguly K; Sharma S; Atri P; Chirravuri-Venkata R; Cox JL; Sayed Z; Jones DT; Ganti AK; Ghersi D; Macha MA; Batra SK
Cancer Lett; 2020 Nov; 492():44-53. PubMed ID: 32738272
[TBL] [Abstract][Full Text] [Related]
2.
Guerrero-Preston R; Lawson F; Rodriguez-Torres S; Noordhuis MG; Pirini F; Manuel L; Valle BL; Hadar T; Rivera B; Folawiyo O; Baez A; Marchionni L; Koch WM; Westra WH; Kim YJ; Eshleman JR; Sidransky D
Cancer Prev Res (Phila); 2019 Apr; 12(4):255-270. PubMed ID: 30777857
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.
Lenze NR; Farquhar D; Sheth S; Zevallos JP; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough WG; Zanation AM; Olshan AF
Laryngoscope; 2021 Jun; 131(6):1301-1309. PubMed ID: 33170518
[TBL] [Abstract][Full Text] [Related]
4. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
5. Integrative genomic analysis identifies ancestry-related expression quantitative trait loci on DNA polymerase β and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma.
Ramakodi MP; Devarajan K; Blackman E; Gibbs D; Luce D; Deloumeaux J; Duflo S; Liu JC; Mehra R; Kulathinal RJ; Ragin CC
Cancer; 2017 Mar; 123(5):849-860. PubMed ID: 27906459
[TBL] [Abstract][Full Text] [Related]
6. Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.
Zandberg DP; Liu S; Goloubeva O; Ord R; Strome SE; Suntharalingam M; Taylor R; Morales RE; Wolf JS; Zimrin A; Lubek JE; Schumaker LM; Cullen KJ
Head Neck; 2016 Apr; 38(4):564-72. PubMed ID: 25488341
[TBL] [Abstract][Full Text] [Related]
7. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
8. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities.
Schrank TP; Han Y; Weiss H; Resto VA
Head Neck; 2011 Jan; 33(1):45-53. PubMed ID: 20848419
[TBL] [Abstract][Full Text] [Related]
9. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
10. Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.
Chaudhary S; Ganguly K; Muniyan S; Pothuraju R; Sayed Z; Jones DT; Batra SK; Macha MA
J Natl Cancer Inst; 2019 Mar; 111(3):233-244. PubMed ID: 30615137
[TBL] [Abstract][Full Text] [Related]
11. Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals.
Fakhry C; Krapcho M; Eisele DW; D'Souza G
Cancer; 2018 May; 124(10):2125-2133. PubMed ID: 29533459
[TBL] [Abstract][Full Text] [Related]
12. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
13. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Chen Y; Li ZY; Zhou GQ; Sun Y
Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
Li R; Dong J; Zhang H; Zhao Q; Li X; Liu X; Ye Y; Deng S; Lin D; Zheng J; Zuo Z
Genomics; 2020 Sep; 112(5):3448-3454. PubMed ID: 32569729
[TBL] [Abstract][Full Text] [Related]
16. Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma.
Xu X; Li R; Zhang L; Zhu G; Ren D; Wu L; Gong X
Diagn Pathol; 2021 Nov; 16(1):110. PubMed ID: 34823553
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
18. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract][Full Text] [Related]
19. Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
Kim HAJ; Zeng PYF; Sorgini A; Shaikh MH; Khan H; MacNeil D; Khan MI; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Patel KB; Boutros PC; Nichols AC
Head Neck; 2022 May; 44(5):1124-1135. PubMed ID: 35187756
[TBL] [Abstract][Full Text] [Related]
20. High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
Lu H; Dai W; Guo J; Wang D; Wen S; Yang L; Lin D; Xie W; Wen L; Fang J; Wang Z
Front Immunol; 2020; 11():573920. PubMed ID: 33101298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
